Drug development can be divided into four phases: discovery, preclinical studies, clinical development and market approval.The Drug Discovery Process involves many different stages and series of actions. Lab-based drug tests are more accurate. We like to say they are more rigorous, more involved, and more defensible in a court of law, all of which are elements certain organizations must consider, particularly heavily regulated industries, like the DOT.
The global Drug Development Testing Services market was valued at US$ 578 million in 2023 and is anticipated to reach US$ 888.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Development Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Development Testing Services.
Report Scope
The Drug Development Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Development Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Development Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
Segment by Type
In Vivo Services
Bio Chemistry Analytical
Microbiology Analytical
Others
Segment by Application
Drug Development
Clinical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Development Testing Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Development Testing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In Vivo Services
1.2.3 Bio Chemistry Analytical
1.2.4 Microbiology Analytical
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug Development Testing Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Development
1.3.3 Clinical Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Development Testing Services Market Perspective (2019-2030)
2.2 Drug Development Testing Services Growth Trends by Region
2.2.1 Global Drug Development Testing Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Development Testing Services Historic Market Size by Region (2019-2024)
2.2.3 Drug Development Testing Services Forecasted Market Size by Region (2025-2030)
2.3 Drug Development Testing Services Market Dynamics
2.3.1 Drug Development Testing Services Industry Trends
2.3.2 Drug Development Testing Services Market Drivers
2.3.3 Drug Development Testing Services Market Challenges
2.3.4 Drug Development Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Development Testing Services Players by Revenue
3.1.1 Global Top Drug Development Testing Services Players by Revenue (2019-2024)
3.1.2 Global Drug Development Testing Services Revenue Market Share by Players (2019-2024)
3.2 Global Drug Development Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Development Testing Services Revenue
3.4 Global Drug Development Testing Services Market Concentration Ratio
3.4.1 Global Drug Development Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Development Testing Services Revenue in 2023
3.5 Drug Development Testing Services Key Players Head office and Area Served
3.6 Key Players Drug Development Testing Services Product Solution and Service
3.7 Date of Enter into Drug Development Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Development Testing Services Breakdown Data by Type
4.1 Global Drug Development Testing Services Historic Market Size by Type (2019-2024)
4.2 Global Drug Development Testing Services Forecasted Market Size by Type (2025-2030)
5 Drug Development Testing Services Breakdown Data by Application
5.1 Global Drug Development Testing Services Historic Market Size by Application (2019-2024)
5.2 Global Drug Development Testing Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Development Testing Services Market Size (2019-2030)
6.2 North America Drug Development Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Development Testing Services Market Size by Country (2019-2024)
6.4 North America Drug Development Testing Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Development Testing Services Market Size (2019-2030)
7.2 Europe Drug Development Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Development Testing Services Market Size by Country (2019-2024)
7.4 Europe Drug Development Testing Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Development Testing Services Market Size (2019-2030)
8.2 Asia-Pacific Drug Development Testing Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Development Testing Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Development Testing Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Development Testing Services Market Size (2019-2030)
9.2 Latin America Drug Development Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Development Testing Services Market Size by Country (2019-2024)
9.4 Latin America Drug Development Testing Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Development Testing Services Market Size (2019-2030)
10.2 Middle East & Africa Drug Development Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Development Testing Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Development Testing Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pacific BioLabs
11.1.1 Pacific BioLabs Company Detail
11.1.2 Pacific BioLabs Business Overview
11.1.3 Pacific BioLabs Drug Development Testing Services Introduction
11.1.4 Pacific BioLabs Revenue in Drug Development Testing Services Business (2019-2024)
11.1.5 Pacific BioLabs Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Drug Development Testing Services Introduction
11.2.4 Catalent Revenue in Drug Development Testing Services Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 ICON
11.3.1 ICON Company Detail
11.3.2 ICON Business Overview
11.3.3 ICON Drug Development Testing Services Introduction
11.3.4 ICON Revenue in Drug Development Testing Services Business (2019-2024)
11.3.5 ICON Recent Development
11.4 ProPharma Group
11.4.1 ProPharma Group Company Detail
11.4.2 ProPharma Group Business Overview
11.4.3 ProPharma Group Drug Development Testing Services Introduction
11.4.4 ProPharma Group Revenue in Drug Development Testing Services Business (2019-2024)
11.4.5 ProPharma Group Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Detail
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Drug Development Testing Services Introduction
11.5.4 WuXi AppTec Revenue in Drug Development Testing Services Business (2019-2024)
11.5.5 WuXi AppTec Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Detail
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Drug Development Testing Services Introduction
11.6.4 Labcorp Revenue in Drug Development Testing Services Business (2019-2024)
11.6.5 Labcorp Recent Development
11.7 MedPharm
11.7.1 MedPharm Company Detail
11.7.2 MedPharm Business Overview
11.7.3 MedPharm Drug Development Testing Services Introduction
11.7.4 MedPharm Revenue in Drug Development Testing Services Business (2019-2024)
11.7.5 MedPharm Recent Development
11.8 Patheon
11.8.1 Patheon Company Detail
11.8.2 Patheon Business Overview
11.8.3 Patheon Drug Development Testing Services Introduction
11.8.4 Patheon Revenue in Drug Development Testing Services Business (2019-2024)
11.8.5 Patheon Recent Development
11.9 CTI
11.9.1 CTI Company Detail
11.9.2 CTI Business Overview
11.9.3 CTI Drug Development Testing Services Introduction
11.9.4 CTI Revenue in Drug Development Testing Services Business (2019-2024)
11.9.5 CTI Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Detail
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher Drug Development Testing Services Introduction
11.10.4 Thermo Fisher Revenue in Drug Development Testing Services Business (2019-2024)
11.10.5 Thermo Fisher Recent Development
11.11 ChemPartner
11.11.1 ChemPartner Company Detail
11.11.2 ChemPartner Business Overview
11.11.3 ChemPartner Drug Development Testing Services Introduction
11.11.4 ChemPartner Revenue in Drug Development Testing Services Business (2019-2024)
11.11.5 ChemPartner Recent Development
11.12 Frontage Labs
11.12.1 Frontage Labs Company Detail
11.12.2 Frontage Labs Business Overview
11.12.3 Frontage Labs Drug Development Testing Services Introduction
11.12.4 Frontage Labs Revenue in Drug Development Testing Services Business (2019-2024)
11.12.5 Frontage Labs Recent Development
11.13 ChemDiv
11.13.1 ChemDiv Company Detail
11.13.2 ChemDiv Business Overview
11.13.3 ChemDiv Drug Development Testing Services Introduction
11.13.4 ChemDiv Revenue in Drug Development Testing Services Business (2019-2024)
11.13.5 ChemDiv Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
听
听
*If Applicable.
